Suzhou Fushilai Pharmaceutical Co., Ltd.

SZSE:301258 Stock Report

Market Cap: CN¥2.4b

Suzhou Fushilai Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Xiangyun Qian

Chief executive officer

CN¥840.2k

Total compensation

CEO salary percentagen/a
CEO tenure11.2yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure2.2yrs

Recent management updates

Recent updates

There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Oct 30
There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

Jun 07
Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

CEO

Xiangyun Qian (55 yo)

11.2yrs

Tenure

CN¥840,200

Compensation

Mr. Xiangyun Qian serves as Chairman and General Manager of Suzhou Fushilai Pharmaceutical Co., Ltd. Mr. Qian is Non-Independent Director of Suzhou Fushilai Pharmaceutical Co., Ltd. from September 12, 2013...


Board Members

NamePositionTenureCompensationOwnership
Xiangyun Qian
Chairman & GM11.2yrsCN¥840.20k0.18%
CN¥ 4.2m
Aijin Bian
Deputy GMno dataCN¥796.80k0.22%
CN¥ 5.2m
Jiangang Lu
Deputy GM of Production & Director5.7yrsCN¥537.50k0.38%
CN¥ 9.2m
Yi Qian
Chairman of the Board of Supervisors and Director of Human Resources & Administrationno datano data0.21%
CN¥ 5.0m
Zhong Chen
Independent Director2.2yrsCN¥100.00kno data
Yingxian Shen
Non-Independent Director8.2yrsno datano data
Chunqing Jin
Independent Director2.2yrsCN¥100.00kno data
Xuezhen Jia
Non-Employee Supervisor2.2yrsno datano data
Chuanxing Cao
Independent Directorless than a yearno datano data

2.2yrs

Average Tenure

49yo

Average Age

Experienced Board: 301258's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.